Çѱ¹°£´ãÃé¿Ü°úÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)HBP Surgery Week 2021 & The 54th Annual Congress of the Korean Association of HBP Surgery : 2021-03-25±³À°ÀÏÀÚ : 2021-03-25
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: ±×·£µå¿öÄ¿ÈúÈ£ÅÚ ¼¿ï)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)HBP Surgery Week 2021 & The 54th Annual Congress of the Korean Association of HBP Surgery ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-557-8422
À̸ÞÀÏ :
hbpsurgery@khbps.org ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 550¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 17 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ȸ¿ø&±¹³»°ÅÁÖ ¿Ü±¹ÀÎ: 150,000¿ø(ÇöÀåÂü°¡), 30,000¿ø(¹öÃò¾óÂü°¡) / ºñȸ¿ø: 200,000¿ø(ÇöÀåÂü°¡), 50,000¿ø(¹öÃò¾óÂü°¡) / Àü°øÀÇ, °£È£»ç, ±ºÀÇ°ü: 50,000¿ø(ÇöÀåÂü°¡), ¹«·á(¹öÃò¾óÂü°¡)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 08:00~11:30 Laparoscopic hepatectomy, Robotic hepatectomy ±è±âÈÆ ÃÖ±âÈ«(¿ï»êÀÇ´ë ¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 08:20~08:30 Analysis of hepatocellular carcinoma prognosis after liver resection and transplantation according to the expression of immune checkpoint inhibitors in the peripheral blood Ȳ½Å(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 08:30~08:40 Epidemiology and future prediction of Korean liver, pancreatic and biliary cancer ÇѼº½Ä(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 08:40~08:50 Development of platform for education and learning in minimally invasive pancreatic surgery ÃÖ¼ºÈÆ(Â÷ÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 08:50~08:55 2021 KAHBPS fund winner 1 TBD(TBD)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 08:55~09:00 2021 KAHBPS fund winner 2 TBD(TBD)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 09:00~09:05 2021 KAHBPS fund winner 3 TBD(TBD)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 09:05~09:10 2021 KAHBPS fund winner 4 TBD(TBD)
Åä·Ð 03¿ù 25ÀÏ Room B 09:10~09:20 Åä·Ð ()
±âŸ 03¿ù 25ÀÏ Room B 09:20~09:40 Opening Ceremony ()
ÈÞ½Ä 03¿ù 25ÀÏ Room B 09:40~10:00 Break ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 10:00~10:20 Multifocal IPMN from the pathological perspective È«½Â¸ð(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 10:20~10:40 How to determine the surgical extent? Sohei SATOI(Kansai Medical University Japan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 10:40~11:00 Intraoperative pancreatic cytology in IPMN Takao OHTSUKA(Kagoshima University Japan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 11:00~11:05 Case discussion with panel and audiences ±èÇü¼±(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 11:05~11:10 Case discussion with panel and audiences ÀåÀçÀ²(°æ»óÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 11:10~11:30 Åä·Ð ()
ÈÞ½Ä 03¿ù 25ÀÏ 11:30~11:40 ÈÞ½Ä ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 11:40~11:47 Elderly living liver donors in Korea ±èÁ¾¸¸(¼º±Õ°ü´ëÇб³ »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 11:47~11:54 Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and liver cirrhosis: A propensity score-matched comparison À±¿µÀÎ(¿ï»ê´ëÇб³ ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 11:54~12:01 Liver transplantation from discarded liver grafts: Expanding the donor liver pool in Mexico Carlos FLOREZ-ZORRILLA(Hospital Puerta de Hierro Andares Guadalajara Mexico)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 12:01~12:08 Performance of Artificial Intelligence in predicting survival following deceased donor liver transplantation: retrospective study using multi-center data from the Korean Organ Transplant Registry (KOTRY) À¯¿µµ¿(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 12:08~12:15 Pure Laparoscopic Living Donor Hepatectomy for the Right Posterior Segment Graft ÇÑÀÚ·É(°æºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 12:15~12:22 Cross-match as an immuno-oncological risk factor for hepatocellular carcinoma recurrence and inferior survival after living donor liver transplantation: A call for further investigation Cheng-Maw HO(National Taiwan University Hospital Taiwan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 12:22~12:29 Intraoperative hepatic artery thrombosis in living donor liver transplantation despite immediate reconstruction increases risk of graft failure È«¼¿µ(¼¿ï´ëÇб³º´¿ø)
Åä·Ð 03¿ù 25ÀÏ Room A 12:29~12:30 Åä·Ð ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 11:40~11:47 A Proteomic Multi-Marker Panel for Detection of Pancreatic Cancer using Multiple Reaction Monitoring-Mass Spectrometry. ±è¿ä¼·(¼¿ï´ëÇб³ °ø°ú´ëÇÐ)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 11:47~11:54 Study on the clinical characteristics of Young age Pancreatic Cancer using KOTUS Registry ±èÇü¼±(¿¬¼¼´ëÇб³ °³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 11:54~12:01 Outcomes of 5,000 pancreatectomies in Korean single referral center and literature reviews º¯À±Çü(ÀÇÁ¤ºÎ À»Áö´ëÇб³º´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 12:01~12:08 Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma È«»ç¶û(¿ï»ê´ëÇб³ ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 12:08~12:15 Changes in total lymphocyte count and neutrophil-to-lymphocyte ratio after curative pancreatectomy in patients with pancreas adenocarcinoma and their prognostic role ±èÀº¿µ(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 12:15~12:22 Initial treatment pattern and prognosis of exocrine pancreatic cancer in Korea from 2006 to 2017 °¹ÌÁÖ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 12:22~12:29 MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer À̼ºÈ¯(ºÐ´çÂ÷º´¿ø)
Åä·Ð 03¿ù 25ÀÏ Room B 12:29~12:30 Åä·Ð ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 12:30~13:00 °£´ãÃé¿Ü°ú¿¡¼ÀÇ ÇغÎÇÐ ÀÌ¿µÁÖ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 13:00~14:00 TBD ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 13:00~14:00 TBD °Ã¢¹«(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:00~14:07 Prediction of microvascular invasion via gadoxetic acid-enhanced MRI in hepatocellular carcinoma: The implication of planning extent of the hepatectomy ȲÇý¼º(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:07~14:14 Development and Validation of An Individualized Prediction Calculator of Postoperative Mortality Within 6 Months After Surgical Resection for Hepatocellular Carcinoma: An International Multicenter Study Tian YANG(Eastern Hepatobiliary Surgery Hospital Second Military Medical University (Navy Medical University) China)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:14~14:21 Integrative multi-omics profiling for resectable hepatocellular carcinoma uncovers clinically available serum biomarkers to predict microvascular invasion °ÀÎõ(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:21~14:28 Ethanol-Induced Intestinal miRNAs in Liver Injury and Early Development of Liver Cancer Je-Hyun YOON(Medical University of South Carolina USA)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:28~14:35 Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma in Korea ±èÁ¾¸¸(¼º±Õ°ü´ëÇб³ »ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:35~14:42 Hepatic and extrahepatic colorectal metastases have discordant responses to systemic therapy. Pathology data from patients undergoing simultaneous resection of multiple tumor sites Pio CORLEONE(Humanitas Clinical and Research Center - IRCCS Italy)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:42~14:49 Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation À¯Áø¼ö(¼º±Õ°ü´ëÇб³ »ï¼º¼¿ïº´¿ø)
Åä·Ð 03¿ù 25ÀÏ Room A 14:49~14:50 Åä·Ð ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:00~14:30 Cholangiocarcinoma: Consensus statement from ENS-CCA Jesús María BAÑALES(Donostia University Hospital Spain)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:30~14:37 Multi-center comparative study between totally laparoscopic and robotic pancreaticoduodenectomy: Propensity score and learning curve matching analysis ÀÌÀçÈÆ(¿ï»ê´ëÇб³ ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:37~14:44 Impact of misclassification of Klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: a population-based national cancer registry study °¹ÌÁÖ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:44~14:51 Precision strategy based on cancer-specific molecular subtypes of bile duct cancer from comprehensive analysis using multi-omics dataset Á¶ÇýÁ¤(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:51~14:58 Clinical implication of tumor location in intrahepatic cholangiocarcinoma and assessment of the current staging system ¼ÕÈñÁÖ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 14:58~15:05 Prognostic impact of perioperative CA19-9 levels in patients with resected perihilar cholangiocarcinoma ÀÌÁ¾¿ì(ÇѸ²´ëÇб³ ¼º½Éº´¿ø)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 15:05~15:12 The triple-checked criteria for drain management after pancreatectomy Daisuke HASHIMOTO(Kansai Medical University Japan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 15:12~15:19 Optimal timing of portal vein embolization (PVE) after preoperative biliary drainage for hilar cholangiocarcinoma À¯¿µÈÆ(À»Áö´ëÇб³º´¿ø)
Åä·Ð 03¿ù 25ÀÏ Room B 15:19~15:20 Åä·Ð ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 14:50~15:20 20 years of LDLT : Lessons learned Yaman TOKAT(International Liver Center Turkey)
ÈÞ½Ä 03¿ù 25ÀÏ 15:20~15:40 Break ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 15:40~16:00 Liver transplantation for post-hepatectomy liver failure Arianeb MEHRABI(University of Heidelberg Germany)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 16:00~16:20 Liver transplantation for acute on chronic liver disease; When and how? ¹ÚÁØ¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 16:20~16:40 Auxiliary liver transplantation for acute liver failure À̳²ÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 16:40~17:00 Bridging therapy for the patient with acute hepatic failure during waiting liver Scott L. NYBERG(Mayo Clinic USA)
Åä·Ð 03¿ù 25ÀÏ Room A 17:00~17:10 Åä·Ð ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 15:40~16:00 Definition and diagnosis of surgical margin in extrahepatic bile duct cancer ±èÇý·É(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 16:00~16:20 Extended surgery according to margin status on frozen section Michiaki UNNO(Tohoku University Japan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 16:20~16:40 Standard radical bile duct surgery focused on vascular reconstruction Ȳ½Å(¿ï»êÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 16:40~16:50 Case discussion 1 ÀÌÈñ¼º(ÀÌÈÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 16:50~17:00 Case discussion 2 ÃÖ»õº°(°í·ÁÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 17:00~17:10 Åä·Ð ()
ÈÞ½Ä 03¿ù 25ÀÏ 17:10~17:20 Break ()
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 17:20~17:28 Upfront Surgery ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 17:28~17:38 Upfront Surgery Shunichi ARIIZUMI(Tokyo Women)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 17:38~17:46 Non-Surgical Treatment ±èº¸Çö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 03¿ù 25ÀÏ Room A 17:46~17:56 Non-Surgical Treatment ÀåÁ¤¿ø(°¡Å縯ÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room A 17:56~18:00 Case Discussion ±èÁ¾¸¸ TBD(¼º±Õ°üÀÇ´ë TBD)
Åä·Ð 03¿ù 25ÀÏ Room A 18:00~18:06 ºÐ°ú: TACE ¿ÀÁ¤¼®(°¡Å縯ÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room A 18:06~18:13 ºÐ°ú: SBRT ¼ºÁø½Ç(¿¬¼¼ÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room A 18:13~18:20 ºÐ°ú: Hepatology À庴±¹(°è¸íÀÇ´ë)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 17:20~17:35 Cons Hiroki YAMAUE(Wakayama Medical University Japan)
±³À°½Ã°£ 03¿ù 25ÀÏ Room B 17:35~17:50 Pros ÇãÁø¼®(¼º±Õ°üÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 17:50~18:05 Case Discussion Ȳȣ°æ(¿¬¼¼ÀÇ´ë)
Åä·Ð 03¿ù 25ÀÏ Room B 18:05~18:20 Case Discussion ½Å»óÇö(¼º±Õ°üÀÇ´ë)